Nurse Practitioner, Family · San Antonio, TX
NPI
1396859211
Since 2006
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
303 E Quincy St, Suite 102
San Antonio, TX, 78215
Phone (210) 229-7242
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.4M
4,010 prescriptions
Company payments, 2025
$4,926
From 32 companies
Medicare prescription drug claims, 2024
In 2024, the drug Thimios D Partalas prescribed most often to Medicare patients was Donepezil Hcl, with 346 prescriptions and refills. In total Thimios D Partalas wrote 4,010 Medicare prescriptions that cost $2.4M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Donepezil Hcl Generic | 346 | 544 | 105 | $2,599 |
| Levetiracetam Generic | 201 | 298 | 45 | $7,027 |
| Topiramate Generic | 186 | 320 | 52 | $1,154 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 175 | 241 | 41 | $2,301 |
| Memantine Hcl Generic | 149 | 220 | 44 | $1,543 |
| Gabapentin Generic | 140 | 171 | 37 | $2,337 |
| Clonazepam Generic | 108 | 125 | 34 | $976 |
| Primidone Generic | 105 | 195 | 26 | $2,778 |
| Trazodone Hcl Generic | 104 | 139 | 32 | $374 |
| Lacosamide Generic | 104 | 127 | 19 | $17K |
| Neupro Rotigotine | 103 | 221 | 35 | $249K |
| Amantadine Amantadine Hcl | 96 | 124 | 17 | $2,837 |
| Memantine Hcl Er Memantine Hcl | 94 | 147 | 25 | $8,138 |
| Buspirone Hcl Generic | 85 | 102 | 25 | $617 |
| Ubrelvy Ubrogepant | 82 | 94 | 17 | $140K |
Brand drugs: 743 claims; generic drugs: 3,250 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thimios D Partalas $4,926 ($4,926 in general payments such as food, travel and fees) from 32 companies. The largest payer was TG Therapeutics, Inc. with $797.
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. TGTX | 28 | $797 |
| Abbvie Inc. ABBV | 31 | $405 |
| Neurocrine BioSciences, Inc. NBIX | 14 | $389 |
| Celgene Corporation BMY | 33 | $365 |
| Teva Pharmaceuticals USA, Inc. TEVA | 11 | $320 |
| EMD Serono, Inc. MRK.DE | 10 | $308 |
| Novartis Pharmaceuticals Corporation NVS | 21 | $306 |
| Eisai Inc. 4523.T | 12 | $224 |
| Biogen, Inc. BIIB | 11 | $201 |
| Lilly USA, LLC LLY | 6 | $172 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.